On September 9, 2009
In TBWA’s New Ads for GSK’s Alli, Loss of Bowel Control Is No Longer a Problem
GlaxoSmithKline’s new advertising for diet drug Alli plays down its famous side effect — loss of bowel control — in favor of more upbeat weight-loss claims since TBWA won the $85 million business.
0 Comments